Kenneth J. Kelley, Director at HALOZYME THERAPEUTICS INC (HTI), sold 25,000 shares at $8.53 ($211K) on 2007-04-09, disclosed to the SEC on 2007-04-10.
Scheduled sale ($211k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.39 | 3,526 | $30K | 14.0% |
| 2 | $8.40 | 1,800 | $15K | 7.1% |
| 3 | $8.41 | 300 | $3K | 1.2% |
| 4 | $8.42 | 300 | $3K | 1.2% |
| 5 | $8.43 | 500 | $4K | 2.0% |
| 6 | $8.44 | 2,481 |
| $21K |
| 9.9% |
| 7 | $8.45 | 1,200 | $10K | 4.8% |
| 8 | $8.46 | 3,000 | $25K | 12.0% |
| 9 | $8.47 | 500 | $4K | 2.0% |
| 10 | $8.48 | 2,300 | $20K | 9.2% |
| 11 | $8.49 | 300 | $3K | 1.2% |
| 12 | $8.50 | 7,700 | $65K | 30.9% |
| 13 | $8.51 | 500 | $4K | 2.0% |
| 14 | $8.52 | 97 | $826 | 0.4% |
| 15 | $8.53 | 196 | $2K | 0.8% |
| 16 | $8.54 | 300 | $3K | 1.2% |
| Total | $8.46 avg | 25,000 | $211K | 100% |
| Filing → |
| HALO | SELL | 2021-02-01 | $469K | — | Filing → |
| HALO | SELL | 2021-01-04 | $417K | — | Filing → |
| HALO | SELL | 2020-12-07 | $1.4M | — | Filing → |